
Glossary · Cold chain & pharma
Good Distribution Practice (GDP) meaning
Good Distribution Practice (GDP) in pharma keeps medicines' quality intact in storage and transport. It is not gross domestic product. See what GDP covers.

Good Distribution Practice (GDP) in pharma keeps medicines' quality intact in storage and transport. It is not gross domestic product. See what GDP covers.
A medicine can leave the factory in perfect condition and still reach a patient damaged, mixed up or replaced by a falsified product. GDP exists to stop that. The WHO guideline on good storage and distribution practices for medical products (TRS 1025, Annex 7, 2020) covers storage and distribution across the supply chain of medical products. In India, CDSCO has published draft guidelines on Good Distribution Practices for pharmaceutical products, prepared in line with the WHO guidance and issued for stakeholder comment, so treat them as guidance rather than final rules. The draft names manufacturers, wholesalers, distributors, logistics providers, transport companies and forwarding agents among those covered.
For the storage part, a GxP temperature monitoring system such as Autowhat's ColdWatch records every reading from freezers and cold rooms in an append-only ALCOA+ audit trail, escalates alarms until someone acknowledges them with a comment, and tracks calibration due dates.
The CDSCO draft is organised around these areas:
The CDSCO draft says storage areas should be temperature mapped under representative conditions, temperature monitoring records should be available for review, and monitoring equipment should be checked and calibrated at defined intervals. It asks for monitoring records to be kept for at least the shelf life of the stored product plus one year. In transport, it says required storage conditions should be maintained within the limits on the packaging, and a deviation should be reported to the distributor and the recipient, with written procedures to investigate it.
Illustrative only. A distributor stores vaccines in a cold room labelled 2 to 8 °C. A door is left ajar during loading and the room reads 9.6 °C for 40 minutes.
| Step | GDP expectation |
|---|---|
| Alarm | The excursion is detected and someone is told, not found at the next round |
| Contain | Affected stock is quarantined, not dispatched |
| Record | Duration, peak and affected batches are documented |
| Decide | QA assesses impact with the manufacturer's stability data before release or rejection |
| Prevent | The cause, here door practice during loading, is fixed through a CAPA |
The full method is in cold room temperature excursion investigation, and typical storage bands are in pharma cold room temperature range.
Where this shows up in our work. ColdWatch: Freezers and cold rooms monitored live, escalating alarms, AI breach prediction and an ALCOA+ audit trail. Book a 30-minute working session with an engineer.
In the pharmaceutical industry, GDP stands for Good Distribution Practice. It is the set of quality rules for storing and transporting medicines so that their quality and identity are maintained until they reach the patient.
GDP guidance is aimed at everyone in the distribution chain: manufacturers, wholesalers, distributors, logistics providers, transport companies and forwarding agents. In India, CDSCO's draft GDP guidelines, which follow WHO's guidance, name these parties.
GMP, Good Manufacturing Practice, controls how a medicine is made. GDP, Good Distribution Practice, controls how it is stored, transported and handed over afterwards, including returns and recalls.